SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds (steroids, small molecules, carbohydrates, epigenetic modifications) and complex antigens (GPCR, ion channels, toxins, transporters, proteins from viral envelopes) thanks to unique technologies (DNA immunization, syngeneic cell immunization, rat-LOU species). Anti-drug antibodies, surrogates, or therapeutics mAbs one-stop-shop solution from antigen to gr manufacturing.
| Website | https://www.synabs.be/custom-monoclonal-antibody-development/ |
| Revenue | $11 million |
| Employees | 8 (8 on RocketReach) |
| Founded | 2015 |
| Address | Rue Auguste Piccard 48, Charleroi, Walloon Region 6041, BE |
| Phone | (328) 164-0103 |
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services |
| Keywords | Antibody Engineering, Therapeutic Antibodies, Custom Antibody Production, Immunotherapy, Drug Development, Protein Engineering, Pharmaceutical Research, Biotechnology, Biopharmaceutical |
| Competitors | Thermo Fisher Scientific, Lonza, MilliporeSigma, GenScript, Bio-Techne, abcam, R&D Systems, Fisher Scientfic, Prosci, Peak Proteins +40 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular SYnAbs employee's phone or email?
The SYnAbs annual revenue was $11 million in 2026.
Julien Isoard is the Chairman and CEO of SYnAbs.
8 people are employed at SYnAbs.
SYnAbs is based in Charleroi, Walloon Region.
The NAICS codes for SYnAbs are [5417, 541, 541713, 54, 54171].
The SIC codes for SYnAbs are [87, 873].